ArticlePDF Available


  • Sinhgad Institute of Pharmaceutical Sciences


The review outlines the current understandings of saponins and sapogenins in agave species with special focus on pharmacological role of hecogenin in numerous preclinical studies. A systematic literature survey was done on the pharmacological activities of hecogenin during the past 40 y with electronic databases like PubMed, Science Direct, Wiley, SciFinder, Google Scholar, Web of Science and Scopus. Hecogenin, a steroidal sapogenin found abundantly in the leaves of Agave genus species such as, Agave sisalana, Agave cantala, Agave aurea and many more. This phytosteroid (hecogenin) is used as initial material for the synthesis of steroidal drugs in the pharmaceutical industry. Hecogenin has exhibited potential role in the management of a number of disorders such as inflammation, arthritis, cancer, gastric ulcer, cardiotonic and larvicidal activity. In this review, we have summarized the saponins and sapogenins present in the Agave species and pharmacological roles of hecogenin with their mechanism of action.
Received: 20 Sep 2019, Revised and Accepted: 25 Dec 2019
The review outlines the current understandings of saponins and sapogenins in agave species with special focus on pharmacological role of hecogenin in
numerous preclinical studies. A systematic literature survey was done on the pharmacological activities of hecogenin during the past 40 y with
electronic databases like PubMed, Science Direct, Wiley, SciFinder, Google Scholar, Web of Science and Scopus. Hecogenin, a steroidal sapogenin found
abundantly in the leaves of Agave genus species such as, Agave sisalana, Agave cantala, Agave aurea and many more. This phytosteroid (hecogenin) is
used as initial material for the synthesis of steroidal drugs in the pharmaceutical industry. Hecogenin has exhibited potential role in the management of
a number of disorders such as inflammation, arthritis, cancer, gastric ulcer, cardiotonic and larvicidal activity. In this review, we have summarized the
saponins and sapogenins present in the Agave species and pharmacological roles of hecogenin with their mechanism of action.
Review Article
Bharati Vidyapeeth University (Deemed to be University), Poona College of Pharmacy, Erandawane, Pune 411038, Maharashtra, India
Keywords: Agave genus, Saponin, Sapogenin, Hecogenin, Pharmacological activities
© 2020 The Authors. Published by I nnovare Academic Sciences Pvt Ltd. This i s an open access article under the CC BY license ( /licens es/by/4.0 /)
DOI: i2.35789. Journal homepage: htt ps://
The genus Agave contains above 400 species growing in dry and
semi-dry environments belongs to the family Agavaceae (fig. 1).
These plants are often called as ‘wild century’, ‘hardy century,’ or
‘rough century’ plants as they are growing in dry lands. The plant is
also known as ‘century plant’ indicates a huge application of Agave
plant [1]. Beverages, fiber and food materials have been obtained
from the agave plants [2]. In the recent times, Agave species have
also been used as a nutraceutical, natural sweeteners, prebiotics,
biofuels and source of steroidal sapogenins [3]. The research work
on Agave saponins was initially presented by Jones et al. in 1932 [4].
Moreover, Agave was considered as a novel and budding source of
sapogenins [5]. Up till now, not less than 50 species of Agave plants
have been discovered for their sapogenin and saponin
phytoconstituents. The previous review work has furnished a
phytochemistry summary of the family belonging to Agavaceae [6].
It comprised of several saponins and sapogenins of Agave such as
Dracaena, Yucca, Cordyline, Nolina, Furcraea and Sansevieria. The
other review entitled traditional products of Agave species has
presented information about Agave food, nutraceutical and
pharmacological properties of extracts [7].
Fig. 1: Different species of Agave genus
International Journal of Pharmacy and Pharmaceutical Sciences
Print ISSN: 2656-0097 | Online ISSN: 0975-1491 Vol 12, Issue 2, 2020
Int J Pharm Pharm Sci, Vol 12, Issue 2, 1-7
Saponins are the glycosides of steroids or triterpenes with numeral
of pharmacological activities like anti-oxidant, immuno-stimulant,
anti-inflammatory, anti-cancer, adjuvant, anti-microbial, hypo-
cholesterolemic properties [8]. In current days, biologists and
chemists are focusing their attention on saponins for the purpose of
new drug discovery [9, 10]. The applicability of these steroidal
compounds has been increasing for therapeutic purpose along with
principal component in the drug discovery methodologies [11].
Over the years, the interest of many researchers has been increasing
due to industrial applicability of steroidal sapogenins. In addition to
this, hecogenin exhibits variety of important biological activities in
the pharmaceutical industry [12, 13]. The steroidal sapogenins
(hecogenin) from Agave genus were reported to have a number of
pharmacological activities such as anti-inflammatory, analgesic, anti-
arthritis, gastroprotective, anticancer and larvicidal activity [14-18].
Overall, the results of numerous pharmacological studies have been
linking the possible use of hecogenin as a novel multi-target based
therapeutic agent against abundant long-lasting disease conditions.
The present review emphasizes on steroidal saponins and
sapogenins of Agave genus with numerous pharmacological
activities with respect to their mechanism of action.
Saponins and sapogenins from agave genus
Different Agave species has been reported for various primary and
secondary metabolites. Carbohydrates [3], Agave syrups as a
functional foods, natural sweeteners, prebiotics [2] are the examples
of primary metabolites from Agave whereas, the examples of
secondary metabolites includes sterols, steroidal saponins and
sapogenins [19], flavonoids [20], homoisoflavonoids [21], tannins
[20], phenolic acids [22], volatile coumarins [20], long chain alkanes,
fatty acids and alcohols [21, 23]. Steroidal saponins and sapogenins
are the most commonly studied compounds in Agave genus.
Two different steroidal sapogenins are identified from the Agave such
as spirostanol-type (1-27) and cholestane-type (Agavegenin D-28). Up
till now, sapogenins of furostanol and furospirostanol skeleton have
not been discovered in Agave genus. 16, 22; 22, 26-
bisepoxycholestanes gives rise to spirostanols sapogenins. The
spirostanol skeleton made up of a tetrahydrofuran ring and a
tetrahydropyran ring attached to C-22 position in a spiran fashion.
Spirostanols sapogenins are isolated from the callus cultures, flowers,
leaves, leaf juice, rhizomes of Agave plants. Spirostanol sapogenins of
Agave differ from each other in terms of a) presence or absence of
carbonyl group at C-12, b) configuration and number of the hydroxyl
moieties attached to the parent nucleus, c) presence or absence of
unsaturation in rings B or C and d) configuration of H at C-5 and C-25.
A hydrophobic aglycone (sapogenin) unit and a hydrophilic sugar
(glycone) unit combines together to form a saponin molecule. The
sugar moieties of Agave saponins include β-D-glucopyranosyl, β-D-
xylopyranosyl, β-D-galactopyranosyl and α-L-rhamnopyranosyls.
The saponins of Agave are classified into two types such as
spirostanol and furostanol glycosides, depending on the basis of
sapogenin nucleus present in it. These compounds are further
classified into monoglycosides, diglycosides, triglycosides,
tetraglycosides, pentaglycosides or hexaglycosides on the basis of
number of sugars moieties attached to it. If the sugar chain is
present at only one position of the sapogenin, it is called as
monodesmosidic. Bidesmosidic saponins contains, two sugar units
located at two different points of sapogenin [24]. The spirostanol
saponins of Agave are monodesmosidic and have sugar unit attached
at the C-3 position of aglycone moiety. Bidesmosidic spirostanol
saponins are relatively very rare in Agave plants.
Reported pharmacological roles of hecogenin
Hecogenin is a steroidal sapogenin (fig. 2) isolated from the leaves of
Agave genus species such as Agave cantala, Agave sisalana, Agave
aurea and many more [25]. The cultivation of hecogenin is extensively
spread throughout the tropical and subtropical regions [26]. Brazil
represents one of the largest producers (69 %) of hecogenin [27].
Hecogenin was reported as an important therapeutic agent due to its
valuable pharmacological properties involving antioxidant, anti-
inflammatory, antifungal, hypotensive, anti-nociceptive [28], larvicidal,
cardioactive, anti-proliferative activity in human osteosarcoma cells
[29] and anti-hyperalgesic effects [30]. Hecogenin also exhibits an anti-
inflammatory effect against gastric mucosal inflammation in rat
induced by ethanol [31]. It is also used in pharmaceutical industry as a
precursor for the synthesis of many steroidal hormone and steroidal
anti-inflammatory drugs [32
Fig. 2: Structure of hecogenin
Anti-inflammatory role of hecogenin
Inflammation is a multidimensional reaction of body tissues to
harmful stimuli. It is a protective mechanism involving the activities
of immune cells, molecular signals and vascular events. During the
inflammation process, a wide range of inflammatory cytokines,
chemical mediators and oxygen-derived free radicals are generated
from the inflammatory and phagocytic cells that causes onset of
inflammation reaction [33]. The treatment of inflammatory diseases
involves the usage of non-steroid anti-inflammatory drugs (NSAID’s)
and other synthetic medications. The NSAID’s and synthetic anti-
inflammatory drugs provide symptomatic relief and have numerous
side effects. These drugs do not change the mechanism of
inflammation, increases drug resistance and display inadequate
target specificity. Hence, to overcome all these problems associated
with synthetic anti-inflammatory drugs, it is needed to search a drug
from natural source without or minimal side effects [33]. Ingawale
and Patel, (2016) have explored the anti-inflammatory effect of
hecogenin against croton oil induced ear edema in mice and cotton
pellet induced granuloma in rat model. Result showed that,
hecogenin significantly decreases the weight of inflamed ear of
croton oil treated mice and percent inhibition of dry weight of
granuloma tissue in cotton pellet induced granuloma model in rat
was also found to be significantly decreased. Further, it also
suppressed the myeloperoxidase and serum levels of Tumour
necrosis factor-α (TNF-α) and Interleukin-6 (IL-6) in cotton pellets
induced granuloma model in rat. The result was further supported
by histopathological analysis of ear tissue that showed significant
decrease in dermal thickness and epidermal hyperplasia of ear
tissue thus confirming its anti-inflammatory activity [16] (fig. 3).
Nociceptive role of hecogenin
The pain sensation plays an imperative role as a protection and an
alerting mechanism against the tissue damage. The endogenous pain
inhibitory systems alter the pain sensations through the descending
pain pathway system and release of neurotransmitter such as
serotonin, noradrenalin, and endogenous opioids. The severity of pain
sensation is reduced by the activation of descending pain pathway that
lessens the transmission of nociceptive information [34]. Gama et al.,
(2013) have studied the anti-noceiceptive effect of hecogenin in tail
flick and rota rod test in mice. In this study, the nociceptive threshold
was evaluated by tail flick test and motor performance by rota rod test
in mice. The intraperitoneal (i. p.) administration of hecogenin acetate
(5−40 mg/kg) increased the tail flick latency time in a dose-dependent
manner whereas; the systemic administration of hecogenin acetate
Int J Pharm Pharm Sci, Vol 12, Issue 2, 1-7
(5−40 mg/kg) increased the Fos positive cells concentration in the
gray mater. The data was further supported by immuno-histochemical
detection of Fos protein expression in the gray mater. In addition to
that, hecogenin acetate has promoted neuronal activation in the gray
mater (main site of descending pain-inhibitory pathways) [35]. These
data have confirmed that hecogenin acetate produces anti-nociceptive
effect through the activation of opioid receptors and by endogenous
analgesic mechanisms [28]. The anti-hyperalgesic activity of hecogenin
acetate was tested in inflammatory models of mice with measurement
of cytokine levels and c-fos expression on spinal cord area. The pre-
treatment of mice with hecogenin acetate (5, 10, or 20 mg/kg; i. p.)
inhibited the progress of mechanical hyperalgesia induced by TNF-α,
carrageenan, dopamine and prostaglandins E2
Fig. 3: Anti-inflammatory role of Hecogenin
. Furthermore, the
immunofluorescence data confirmed that pre-treatment of mice with
hecogenin acetate, significantly inhibited Fos expressions in the dorsal
horn of spinal cord after carrageenan induced inflammation. The
present results suggest that hecogenin acetate attenuates mechanical
hyperalgesia by blocking c-fos expression in the spinal cord and by
reduction of pro-inflammatory cytokines, such as interleukin-1β (IL-
1β) [30] (fig. 4).
Fig. 4: Nociceptive role of Hecogenin
Larvicidal role of hecogenin
Dengue is a viral disease caused by the dengue virus, belonging to
the family Flaviviridae. Dengue is communicated by several
mosquito species of the genus Aedes, mainly Aedes aegypti. The
control of dengue is depends on the mosquito combat, through the
use of chemical insecticides. Oliveira et al., (2014), have examined
the larvicidal activity of hecogenin acetate against Aedes aegypti
Int J Pharm Pharm Sci, Vol 12, Issue 2, 1-7
larvae. Experimental result indicated that the hecogenin acetate
does not killed larvaes in the first 24 and 48 h, killed 10% of larvaes
after 72 h, 80% of larvaes after 96 h and 95% of larvaes in 120 h in
the concentration. The probable mechanism of larvicidal activity of
hecogenin acetate was mimicking the insect growth hormone,
preventing its development and death of virus [36] (fig. 5).
Fig. 5: Larvicidal role of hecogenin
Gastroprotective role of hecogenin
Gastric ulcer is a lesion on the mucosal epithelium of the stomach on
exposure to excessive acid and destructive pepsin [37]. Gastric
ulceration is the very common gastrointestinal disorder, accounting
for 15 mortality cases out of every 15,000 complications in the world
per year [38]. The treatment of gastric ulcer involves the usage of
various techniques and medications such as vagotomy, prostaglandin
analogs, H2
The gastroprotective activity of hecogenin was studied in ethanol
and indomethacin induced gastric ulcer in mice. Hecogenin pre-
treatment in rats significantly reduced the gastric lesion in ethanol
and indomethacin induced gastric ulcer in rats. The levels of lipid
peroxidation and nitrite were found to be decreased with increased
cyclooxygenase-2 (COX-2) expression. The gastroprotective effect of
hecogenin was exhibited due to the synthesis of prostaglandin,
opening of K
receptor antagonists and antacids to proton pump
inhibitors. But, the above treatment is associated with gastrointestinal
toxicity specifically due to NSAID’s [39]. Currently available synthetic
antiulcer drugs like ranitidine, cimetidine, misoprostol, omeprazole
and esomeprazole are used for the management and treatment of
NSAID induced gastric ulcer. But, these drugs are associated with
simpler to severe side effects, provoking a search for non-toxic,
affordable and easy availability of antiulcer medication [40, 41].
Exploration on the phytosteroids of medicinal plants that are widely
used in the traditional systems of medicine might provide efficient
remedy for the gastric ulcer treatment.
ATP channels and decreasing release of
myeloperoxidase from neutrophils in vitro. These gastroprotective
effects were confirmed by histological data of hecogenin in ethanol
induced gastric ulcer in rats. The probable mechanism behind the
gastroprotective activity would be antioxidant properties,
generation of free radicals by increasing the glutathione level and
the blockade of lipoperoxidation [14] (fig. 6).
Fig. 6: Gastroprotective role of hecogenin
Int J Pharm Pharm Sci, Vol 12, Issue 2, 1-7
Anti-rheumatic role of hecogenin
Rheumatoid arthritis is a systemic and chronic autoimmune joint
disorder characterized by inflammation of the synovial membrane,
hyperplasia, cartilage and functional disability of joints due to
imbalance between pro-inflammatory and anti-inflammatory
cytokines lead to auto-immunity sensitization and chronic
inflammation [42, 43]. Inflammatory mediators play an imperious
role in the joint inflammation and damage process during the
development of rheumatoid arthritis [44]. The drug treatment of
rheumatoid arthritis have been transformed from conventional non-
steroidal anti-inflammatory drugs including aceclofenac, ibuprofen
and naproxen with prednisone hormones and or disease-modifying
anti-rheumatic drugs such as sulfasalazine, methotrexate and
leflunomide to novel biological agents such as decoy TNF-α receptor
and TNF-α antibody [45]. But, these treatments are allied to several
side effects such as hematologic toxicity, gastrointestinal
nephropathy, ulcerogenicity, cardiovascular complication and
therefore, increase the cost of therapy [25]. Therefore, it is utmost
emergency to develop a safer, new, efficient and economical agent
for the treatment of rheumatoid arthritis.
Liagre et al., (2007) reported the anti-inflammatory effects of
hecogenin in rheumatoid arthritis synovial cell survival. The results
of study have shown that hecogenin inhibited the proliferation and
induced apoptosis of human rheumatoid arthritis. The apoptosis
induced by hecogenin was associated with overexpression of COX-2
enzyme activity correlated with the overproduction of endogenous
prostaglandins E2, activation of mitogen activated protein kinase,
DNA fragmentation, activation of caspase-3 and 9 a major markers of
apoptosis [46]. Ingawale and Patel, 2018 have reported the anti-
arthritic activity of hecogenin through the suppression of pro-
inflammatory cytokines in complete freund’s adjuvant induced
arthritis in rats. Results of the study have shown that hecogenin
elicited significant reduction in the paw edema, arthritic score and
joint diameter along with inhibition of joint destruction in
histopathological and radiological analyzes of ankle joint. The
biochemical level of serum transaminase serum phosphatase,
myeloperoxidase level, haematological parameters such as
haemoglobin, blood cells and inflammatory cytokines levels such as
TNF-α, IL-6, Interleukin-12 (IL-12) and Thromboxane B2 (TXB 2
Fig. 7: Anti-rheumatic role of hecogenin
were found to be decreased after the treatment of hecogenin. The
anti-arthiritc effect was supported by histopathological and COX-2
mRNA expression of rats. In histopathological analysis, the ankle
joint treated with hecogenin showed pronounced inhibition of joint
space narrowing, soft tissue swelling and bone erosion of ankle joint.
The COX-2 expression of the hecogenin treated rats exhibited
reduced levels of COX-2 mRNA enzymes indicating the anti-arthiritc
activity of hecogenin [17] (fig. 7).
Fig. 8: Anti-cancerous role of hecogenin
Int J Pharm Pharm Sci, Vol 12, Issue 2, 1-7
Anti-cancer role of hecogenin
Cancer is one of the world’s most health concern and act as a
primary medicinal chemistry and pharmacology targets. Breast
cancer is the most common malignancy condition affecting the
females worldwide. Breast cancer accounts for 25% of all the cancer
cases and 15% of cancerous deaths among females [47].
Furthermore, breast cancer is considered as the leading cause of
disability due to the deficiency of early diagnosis and effective
treatments. Chemotherapy is the reputable forefront treatment for
the treatment of cancer, but selectivity and off-target side effects are
leading concerns. The treatment from cytotoxic chemotherapy has
been surprising changed to successful molecular targeted cancer
therapy, with significant safety [48].
Elsayed et al., (2017) have studied the anticancer effect of hecogenin
thiosemicarbazone analogs as novel mitogen activated protein
kinase/extracellular signal-regulated kinase (MEK) inhibitors for the
control of breast cancer. In this study they have prepared thirty three
analogs and tested on various in vitro (cell proliferation, cytotoxicity
assay, lactate dehydrogenase release assay, migration assay, invasion
assay, protein extraction and immunoblotting assay) and in vivo model
(orthotopic xenograft model by using MDA-MB-231/GFP human breast
cancer cells), among which hecogenin 12-(30-methylphenyl
thiosemicarbazone) have demonstrated the most potent anti-
proliferative, anti-migratory and anti-invasive activities at low
concentration level [18]. Cruz et al., (2016) have reported that cytotoxic,
genotoxic and mutagenic effects of hecogenin on HepG2 cells. Hecogenin
cytotoxicity was studied by performing MTT assay. Genotoxic and
mutagenic potentials of hecogenin were assessed by comet assay and
cytokinesis-block micronucleus assay. The result revealed that cell
treated with hecogenin, no cytotoxic effect was observed on HepG2 cells
in 10 μm and 50 μm concentrations range. Furthermore, exposure of
cells to 100 μm of hecogenin demonstrated a slight reduction in cell
viability, whereas treatments with concentration above than 100 μm, cell
viability decreased significantly by 30% [49] (fig. 8).
The current review article emphasized on the phytochemistry of
saponins and sapogenins especially hecogenin isolated from Agave
plants and their pharmacological roles. Hecogenin (steroidal saponin)
found in a number of agave species is reported to have variety of
multidimensional biological and therapeutic effects including anti-
inflammatory, anti-cancer, anti-rheumatic, gastroprotective, larvicidal,
nociceptive activities. Because of this reason, hecogenin is a main
biomolecule of interests in the prevention or treatment of numerous
illnesses. The protective effects of hecogenin are due to multiple
mechanisms including suppression of myeloperoxidase levels and
serum levels of TNF-α and IL-6 in inflammation model, anti-
nociceptive effect through the activation of opioid receptors and
blocking c-FOS expression in the spinal cord and reducing the level of
pro-inflammatory cytokines such as IL-, gastroprotective effect due
to antioxidant properties, generation of free radicals by increasing the
glutathione level and the blockade of lipid peroxidation, anti-arthritic
effect due to reduced levels of COX-2 mRNA enzymes and serum pro-
inflammatory cytokines such as TNF-α, IL-6, IL-12 and TXB2
. From
these collected information we can conclude that hecogenin has
various exciting pharmacological potential such as anti-inflammatory,
anti-nociceptive, antimicrobial, gastroprotective, anti-rheumatic,
anticancer and larvicidal aspects.
The authors want to acknowledge Poona college of Pharmacy, Pune
for online article support.
All the have been carried out by me.
The author has no conflicts of interest to declare.
1. Hackman DA, Giese N, Markowitz JS, McLean A, Ottariano SG,
Tonelli C, et al. Agave (Agave americana): an evidence-based
systematic review by the natural standard research
collaboration. J Herb Pharmacother 2006;6:101-22.
2. Nava Cruz NY, Medina Morales MA, Martinez JL, Rodriguez R,
Aguilar CN. Agave biotechnology: an overview. Crit Rev
Biotechnol 2015;35:546-9.
3. Mellado Mojica E, Lopez MG. Identification, classification, and
discrimination of agave syrups from natural sweeteners by
infrared spectroscopy and HPAEC-PAD. Food Chem
4. Jones HD, Furbeck GN, Colorado R. Isolation and study of the
saponin content of the juice and leaf of the agave plant,
Maguey, Manso fino. J Am Pharm Assoc 1932;21:787-93.
5. Marker RE, Wagner RB, Ulshafer PR, Wittbecker EL, Goldsmith
DPJ, Ruof CH. Steroidal sapogenins. J Am Chem Soc
6. Simmons Boyce J, Tinto WF. Steriodal saponins and sapogenins
from the Agavaceae family. Nat Prod Commun 2007;2:99-114.
7. Santos Zea L, Maria Leal Diaz A, Cortes Ceballos E, Gutierrez
Uribe JA. Agave (Agave spp.) and its traditional products as a
source of bioactive compounds. Curr Bioact Compd
8. Guclu Ustundag O, Mazza G. Saponins: properties, applications
and processing. Crit Rev Food Sci Nutr 2007;47:231-58.
9. Thakur M, Melzig MF, Fuchs H, Weng A. Chemistry and
pharmacology of saponins: special focus on cytotoxic
properties. Bot: Targets Ther 2011;1:19-29.
10. Elekofehinti OO. Saponins: anti-diabetic principles from
medicinal plants: a review. Pathophysiol 2015;22:95-103.
11. Jiang S, Fan J, Wang Q, Ju D, Feng M, Li J, et al. Diosgenin induces
ROS dependent autophagy and cytotoxicity via mTOR signaling
pathway in chronicmyeloid leukemia cells. Phytomedicine
12. Huang B, Du D, Zhang R, Wu X, Xing Z, He Y, et al. Synthesis,
characterization and biological studies of diosgenyl analogues.
Bioorganic Med Chem Lett 2012;22:7330-4.
13. Chen Y, Tang YM, Yu SL, Han YW, Kou JP, Liu BL, et al. Advances
in the pharmacological activities and mechanisms of diosgenin.
Chin J Nat Med 2015;13:578-87.
14. Cerqueira GS, Silva GDS, Vasconcelos ER, Fragoso de FAP,
Arcanjo MB, Silveira MD, et al. Effects of hecogenin and its
possible mechanism of action on experimental models of
gastric ulcer in mice. locamrahP J ruE 2012;683:260-9.
15. de Oliveira Rocha HA, Souza do Amaral V. Effect of hecogenin
on DNA instability. 23TToxicol Rep 23T2016;23T323T:539-43.
16. Ingawale DK, Patel SS. Anti-inflammatory potential of
hecogenin in experimental animals: possible involvement of
inflammatory cytokines and myeloperoxidase. Drug R es
17. Ingawale DK, Patel SS. Hecogenin exhibits anti-arthritic activity
in rats through suppression of pro-inflammatory cytokines in
complete freund's adjuvant induced arthritis.
Immunopharmacol Immunotoxicol 2018;401:59-71.
18. Elsayed HE, Ebrahim HY, Haggag EG, Kamal AM, El Sayed KA.
Rationally designed hecogenin thiosemicarbazone analogs as
novel MEK inhibitors for the control of breast malignancies.
Bioorganic Med Chem 2017;25:6297-312.
19. Hernandez Valle E, Herrera Ruiz M, Salgado GR, Zamilpa A,
Ocampo ML, Aparicio AJ, Tortoriello J, et al. Anti-inflammatory
effect of 3-O-[(6'-O-Palmitoyl)-β-d-glucopyranosyl Sitosterol]
from Agave angustifolia on ear edema in mice. Molecules
20. Ahumada Santos YP, Montes Avila J, de Jesus Uribe Beltran M,
Diaz Camacho SP, Lopez Angulo G, Vega Avina R, et al. Chemical
characterization, antioxidant and antibacterial activities of six
Agave species from Sinaloa, Mexico. Ind Crop Prod
21. Morales Serna JA, Jimenez A, Estrada Reyes R, Marquez C,
Cardenas J, Salmon M. Homoisoflavanones from Agave
tequilana weber. Molecules 2010;15:3295-301.
Int J Pharm Pharm Sci, Vol 12, Issue 2, 1-7
22. Almaraz Abarca N, Delgado Alvarado EA, Antonio Avila Reyes J,
Uribe Soto JN, Gonzalez Valdez LS. The phenols of the genus
Agave (Agavaceae). J Biomat Nanobiotechnol 2013;4:9-16.
23. Rizwan K, Zubair M, Rasool N, Riaz M, Zia-Ul-Haq M, de Feo V.
Phytochemical and biological studies of Agave attenuata. Int J
Mol Sci 2012;13:6440-51.
24. Agrawal PK, Jain DC, Pathak AK. NMR spectroscopy of steroidal
sapogenins and steroidal saponins: an update. Magn Reson
Chem 1995;33:923-53.
25. Paik SY, Kok KH, Beak SM, Paek SH, Kim JA. The essential oils
from Zanthoxylum schinifolium pericarp induce apoptosis of
HepG2 human hepatoma cells through increased production of
reactive oxygen species. Biol Pharm Bull 2005;28:802-7.
26. Eskander J, Lavaud C, Harakat D. Steroidal saponins from the
leaves of Agave macroacantha. Fitoterapia 2010;81:371-4.
27. Santos J, Vieira I, Braz Filho R, Branco A. Chemicals from Agave
sisalana biomass: isolation and identification. Int J Mol Sci
28. Gama KB,
Quintans JS, Ant oniolli AR, Quintans Junior LJ,
Santana WA, Branco A, et al. Evidence for the involvement of
descending pain-inhibitory mechanisms in the antinociceptive
effect of hecogenin acetate. J Nat Prod 2013;76:559-63.
30. Quintans JSS, Barreto RSS, de Lucca W, Villarreal CF, Kaneto
CM, Soares MBP, et al. Evidence for the involvement of spinal
cord-inhibitory and cytokines modulatory mechanisms in the
anti-hyperalgesic effect of hecogenin acetate, a steroidal
sapogenin-acetylated, in mice. Molecules 2014;19:8303-16.
Corbiere C, Liagre B, Bianch A, Bordji K, Dauça M, Netter P,
Beneytout JL. Different contribution of apoptosis to the anti-
proliferative effects of diosgenin and other plant steroids,
hecogenin and tigogenin, on human 1547 osteosarcoma cells.
Int J Oncol 2003;22:899-905.
31. Morikawa T, Li N, Nagatomo, A Matsuda H, Li X, Yoshikawa M.
Triterpene saponins with gastroprotective effects from tea seed
(the seeds of Camellia sinensis). J Nat Prod 2006;69:185-90.
32. Serafini LJ, Quintans MR, Antoniolli JSS, Viana dos Santos MR,
Quintans Junior LJ. Mapeamento de tecnologias patenteaveis
com o uso da hecogenina. Rev Geintec 2012;2:
33. Vinueza D, Lopez E, Acosta K, Abdo S. Assessment of anti-
inflammatory activity and cytotoxicity of freeze dried
hydroalcoholic extract of bidens andicola on isolated
neutrophils. Asian J Pharm Clin Res 2017;10:160-3.
34. Akanda MR, Park BY. Involvement of MAPK/NF-kappab signal
transduction pathways: Camellia japonica mitigates inflammation
and gastric ulcer. Biomed Pharmacother 2017;95:1139-46.
35. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive
actions of the descending noradrenergic and serotonergic
systems in the spinal cord. J Pharmacol Sci 2006;101:107-17.
36. Oliveira L, Lacerda D, Nunes F. Effects of hecogenin on
larvicidal activity against Aedes aegypti mosquito, the dengue
vector. BMC Proc 2014;8:P33.
37. Khazaei M, Salehi H. Protective effect of Falcaria vulgaris
extract on ethanol induced gastric ulcer in rat. Iranian J
Pharmacol Ther 2006;5:1-4.
38. Sonnenberg A. Geographic and temporal variations in the
occurrence of peptic ulcer disease. Scand J Gastroenterol Suppl
39. Shristi B, Neha J, Indu BP, Rajesh G. A review on some Indian
medicinal plants for antiulcer activity. J Sci Res Pharm
40. Griffin MR, Scheiman JM. Prospects for changing the burden of
nonsteroidal anti-inflammatory drug toxicity. Am J Med
41. Akah PA, Orisakwe OE, Gamanies KS, Shittu A. Evaluation of
nigerian traditional medicines: II. Effects of some Nigerian folk
remedies on peptic ulcer. J Ethnopharmacol 1998;62:123-7.
42. Hawkins C, Hanks GW. The gastroduodenal toxicity of
nonsteroidal anti-inflammatory drugs. A review of the
literature. J Pain Symptom Manage 2000;202:140-51.
43. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. Emery,
new therapies for treatment of rheumatoid arthritis. Lancet
44. Nishat F, Syeda JF. Pharmacological screening for anti-
arthritic activity of Moringa oleifera. Asian J Pharm Clin Res
45. Tastekin N, Aydogdu N, Dokmeci D, Usta U, Birtane M, Erbas H,
et al. Protective effects of l-carnitine and alpha-lipoic acid in
rats with adjuvant arthritis. Pharmacol Res 2007;56:303-10.
46. Liagre B, Vergne Salle P, Leger DY, Beneytout JL. Inhibition of
human rheumatoid arthritis synovial cell survival by hecogenin
and tigogenin is associated with increased apoptosis, p38
mitogen-activated protein kinase activity and upregulation of
cyclooxygenase-2. Int J Mol Med 2007;20:451-60.
47. Saka S, Singh AN, Sharma N. Potential anti-cancer superfoods: a
minireview. Int J Curr Pharm Res 2016;8:19-21
48. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J, Jemal A.
Global cancer statistics. CA Cancer J Clin 2012;652:87-108.
49. Cruz MS, Cabral Barroso S, Navoni JA, Rocha Silva Teles MM,
Barbosa-Filho JM, de Oliveira Rocha HA, et al. Effect of
hecogenin on DNA instability. Toxicol Rep 2016;3:539-43.
ResearchGate has not been able to resolve any citations for this publication.
Full-text available
Hecogenin is a steroidal sapogenin isolated from the leaves of Agave genus species that plays an important role in the treatment of a variety of inflammatory diseases. The aim of the present study was to evaluate the anti-arthritic activity of hecogenin in Complete Freund’s adjuvant-induced arthritis in rats. The hecogenin (40 µl of 50 µg/kg, orally) and hecogenin + fluticasone (40 µl of 25 µg/kg, each, orally) was tested against Complete Freund’s adjuvant-induced arthritis in rats by evaluating various parameters such as paw volume, arthritic score, joint diameter, spleen weight, thymus weight, haematological and biochemical parameters and pro-inflammatory cytokines. Histopathological and radiological analyzes of ankle joints were also carried out. Treatment of rats with hecogenin and its combination elicited significant reduction in paw edema, arthritic score and joint diameter. Hecogenin and its combination also inhibited joint destruction in histopathological and radiological analyzes of ankle joint. Hecogenin and its combination significantly increased the levels of red blood cells and hemoglobin but decreased the white blood cell count. The anti-arthritic activity was also confirmed with the change in biochemical parameters and myeloperoxidase assay. In the present investigation, hecogenin and its combination prevent destruction of cartilage and protect synovial membrane with improving health status through haematonic properties and down regulation of various cytokines. Hence, hecogenin may be a potential therapeutic candidate for the treatment of rheumatoid arthritis.
Full-text available
Gastric ulcer is an important risk factor for human health globally. Camellia japonica (CJ) is a plant of which the fruits are used as traditional phytomedicine for inflammatory and immunomodulatory diseases; however, the underlying molecular mechanism has not been clarified. The present study aimed to investigate the immunopharmacological activities of Camellia japonica and validate its pharmacological targets. To evaluate the protective roles of Camellia japonica on LPS-induced inflammation in RAW 264.7 cells and HCl/EtOH-induced gastric ulcer in mice; we applied 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), nitric oxide (NO), reactive oxygen species (ROS), histopathology, malondialdehyde (MDA), quantitative real-time polymerase chain reaction (qPCR), immunohistochemistry (IHC), and western blot analyses. We also determined the total phenolic and flavonoid content of Camellia japonica which might possess antioxidant and anti-inflammatory properties. We found the production of NO and ROS in RAW 246.7 cells were both suppressed by Camellia japonica. Moreover, Camellia japonica mitigated the HCl/EtOH-induced oxidative stress in gastric mucosa via the reduction of lipid peroxidation and elevation of NO production. Gastric mucosal damages were prominently improved by Camellia japonica, as confirmed by the histopathological evaluation. The gene expression of inflammatory cytokines and enzymes TNF-α, IL-6, IL-1β, iNOS, and COX-2 was notably downregulated by Camellia japonica. In addition, Camellia japonica markedly attenuated the MAPKs (ERK1/2, JNK, and p38) phosphorylation, COX-2 expression, and activation of transcription factor NF-κB and as well as degradation and phosphorylation of IκBα in gastric mucosa. Taken together, the intimated anti-inflammatory and gastroprotective mechanism of Camellia japonica is mediated by modulation of oxidative stress, inflammatory cytokines, and enzymes via suppression of MAPK/NF-κB signaling pathways.
Full-text available
Objective: The aim of this study was to evaluate anti-inflammatory activity and cytotoxicity in vitro of hydroalcoholic extract of Bidens andicola.Methods: B. andicola hydroalcoholic extract was obtained from aerial parts of B. andicola, following a standardized methodology. Briefly, aerial parts of B. andicola were extracted with ethanol 70% v/v and defatted with n-hexane, hydroalcoholic fraction was concentrated under controlled conditions in a rotary evaporator, and finally the residue was freeze-drying to obtain the hydroalcoholic extract of B. andicola. Anti-inflammatory activity and cytotoxicity assays were carried out using in vitro isolated neutrophils model using stable water-soluble tetrazolium salts.Results and Conclusions: The in vitro anti-inflammatory assay on isolated neutrophils demonstrated that the hydroalcoholic extract showed antiinflammatoryactivity compared to aspirin, with inflammatory inhibition percent values of 80.138±0.729 to hydroalcoholic extract of B. andicola and 82.117±0.762 to aspirin, each tested in five replicates at the concentration of 200 ppm of hydroalcoholic extract or reference.
Full-text available
Hecogenin is a sapogenin found in Agave species in high quantities and is responsible for the many therapeutic effects of these medicinal plants. In addition, this compound is also widely used in the pharmaceutical industry as a precursor for the synthesis of steroidal hormones and anti-inflammatory drugs. Despite Hecogenin being widely used, little is known about its toxicological properties. Therefore, the present study aimed to investigate the cytotoxic, genotoxic and mutagenic effects of Hecogenin on HepG2 cells. Cytotoxicity was analyzed using the MTT test. Then, genotoxic and mutagenic potentials were assessed by comet assay and cytokinesis-block micronucleus assay, respectively. Cytotoxic effect was observed only when cells were exposed to concentrations of Hecogenin equal or higher than 100 μM. Although a lower concentration of Hecogenin caused DNA damage, a reduction on nuclear mutagenic markers in HepG2 cells were observed. The results indicated that Hecogenin treatment generated DNA damage, but in fact it would be repaired, avoiding dissemination of the damage throughout the cell division. Further studies need to be performed to confirm the observed protective effect of Hecogenin against genomic instability.
Natural products have documented oncology success history as valuable scaffolds for selective target modulation. Herein, the sapogenin hecogenin (1) was screened for its anti-breast cancer inhibitory capacity using in vitro assays, including proliferation, cytotoxicity, migration, invasion assays, and Western blotting. The results identified 1 as a propitious hit with modest activities attributed to the concurrent down-regulation of mitogen activated protein kinase kinase/extracellular signal-regulated kinase (MEK) distinctive downstream effectors. Guided by in silico 3D-structural insights of MAPK kinase domain, an extension strategy was adopted at 1's C-3 and C-12 aimed at the design of novel hecogenin-based analogs with improved target binding affinity. Thirty-three analogs were prepared and tested, among which hecogenin 12-(3'-methylphenyl thiosemicarbazone) (30) displayed the most potent selective anticancer effects. Analog 30 demonstrated antiproliferative, antimigratory and anti-invasive activities at low μM level, compared to the negligible effect on the non-tumorigenic MCF-10A mammary epithelial cells. Durable regression of breast tumor xenografts in athymic nude mice was observed after treatments with 30, compared to its parent hecogenin at the same dose regimen, confirmed the hit-to-lead promotion of this analog. Hecogenin-12-thiosemicarbazones, represented by 30, is a novel MEK inhibitory lead class to control breast neoplasms.
Cancer, a leading cause of mortality worldwide, has gained much attention and concern for its debilitating effects. Among the various oncological treatments and therapies like surgery, radiation, hormonal therapy, immune therapy, targeted therapy, Chemoprevention or Chemotherapy has recently being recognized as a promising strategy for prevention of afflicting disease like cancer. Chemoprevention is the use of natural or synthetic agents (alone or in combination) to suppress or prevent the process of oncogenesis. The role of diet and nutrition in cancer development has been overlooked for decades, despite of its strong scientific evidence. Only in recent years, plants, vegetables, herbs and spices of traditional diet and medicines have been accepted as one of the main sources of chemo preventive substances.
Hecogenin is a steroidal sapogenin plays important role in treatment of variety of inflammatory diseases. We have investigated the anti-inflammatory effects of Hecogenin (50 µg/animal) (HG), Fluticasone (50 µg/animal) (FC) and Hecogenin+Fluticasone (HG+FC) combination (25 µg/animal, each) on various inflammatory models. The anti-inflammatory effect of HG, FC and HG+FC combination was studied on % inhibition of dry weight of granuloma tissue, Δ ear weight, myeloperoxidase assay, serum pro-inflammatory cytokines, colon weight to length ratio, macroscopic lesions, adhesion score, diarrhoea score and histopathological analysis of ear and colon tissue on Cotton pellets induced granuloma in rats, Croton oil induced ear edema in mice and TNBS induced granuloma in rats. Topical administration of HG and its combination with FC showed significant decrease (p<0.001) in the % inhibition of dry weight of granuloma tissue, Δ ear weight, myeloperoxidase level, serum pro-inflammatory cytokines levels, colon weigh to length ratio as compared with Cotton pellets treated with acetone groups and Croton oil treated animals. Further histopathological analysis of ear tissue showed significant decrease in dermal thickness and epidermal hyperplasia and colon tissue showed reduction of edema, infiltration of inflammatory cells and normalization of crypt structure compared to DC animals. Thus, the findings of present study suggest the possible role of HG in the treatment of inflammation by reducing the dose of FC in combination with HG. © Georg Thieme Verlag KG Stuttgart · New York.
Objective: The present study was performed to investigate the anti-arthritic activity of ethanolic and aqueous leaf extracts of Moringa oleifera (MO) against formaldehyde-induced arthritis in laboratory rats. Methods: Arthritis was induced in albino Wistar rats by administration of 0.1 ml formaldehyde (2% v/v, sc) into subplantar region of the right hind paw. Diclofenac sodium (10 mg/kg, i.p.) was used as the standard drug. The ethanolic leaf extracts of MO at doses of 250 and 500 mg/kg and aqueous leaf extract at 500 mg/kg body weight p.o were administered for 10 days. At the end of the study period, changes in paw edema volume, paw thickness, arthritis score, and C-reactive protein (CRP) levels were recorded along with histopathology of knee joints in all groups were studied. Results: There was a significant reduction recorded in paw edema volume, paw thickness, arthritis score, and CRP levels on treatment with diclofenac sodium, ethanolic and aqueous extracts of MO. When compared between the two extracts, aqueous extract in the dose of 500 mg/kg body weight was found to be more potent. Conclusion: The results demonstrated significant anti-arthritic activity of ethanolic and aqueous leaf extracts of MO at a dose of 500 mg/kg body weight. © 2016, Innovare Academics Sciences Pvt. Ltd. All rights reserved.
Background Diosgenin, a steroidal saponin isolated from legumes and yams, has been confirmed to possess potent anticancer effect on multifarious tumors including chronic myeloid leukemia (CML). Purpose We aimed to further determine the anti-cancer activity of diosgenin and its mechanisms in CML cells. Methods The cell vitality was detected by MTT assay. Autophagic flux and reactive oxygen species (ROS) production were analyzed by laser scanning confocal microscope. Apoptosis was observed by flow cytometry. All proteins expression was examined by western blotting. Results Autophagy induction was demonstrated by examination of autophagic flux including autophagosomes accumulation, autophagosome–lysosome fusion and degradation of autophagosomes. Moreover, blocking autophagy with inhibitor chloroquine (CQ) and 3-methyladenine (3-MA), enhanced diosgenin-induced apoptosis, indicating the protective effect of autophagy in diosgenin-treated CML cells. Further study suggested that diosgenin-induced autophagy and cytotoxicity were accompanied by reactive oxygen species (ROS) generation and mammalian target of rapamycin (mTOR) signaling pathway inhibition. N-acetyl-L-cysteine (NAC) administration, a scavenger agent of ROS, could down-regulate diosgenin-induced autophagy via reversion of mTOR pathway inhibition. Conclusion These results indicate that diosgenin obviously generates ROS and this oxidative pressure not only produces cytotoxic effect on CML cells but also induces autophagy. What's more, autophagy functions as a cytoprotective mechanism to overcome cytotoxicity of diosgenin in tumor cells and inhibition of autophagy can enhance the anti-CML activity of diosgenin.